Tocopherol

Lymphedema

M.D. Anderson Cancer CenterPhase 2Active

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 89/ 100

Competitive context

6 Active assets in the Lymphedema cohort.

Asset / Sponsor	Phase	Rating
Pycnogenol National Center for Complementary and Integrative Health (NCCIH)	Phase 2	B
TACROLIMUS Odense University Hospital	Phase 2/3	B
Lymfactin® Herantis Pharma Plc.	Phase 2	B
Sodium Selenite University Health Network, Toronto	Phase 2	B
Pentoxifylline M.D. Anderson Cancer Center	Phase 2	B

View all 17 →

Same molecule, other indications

Tocopherol is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant

B

Indicative ·

62 / 100

breast cancerDormant

B

Indicative ·

60 / 100

chronic hepatitis C virus infectionDormant

B

Indicative ·

60 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.